中国角膜屈光手术围手术期干眼诊疗专家共识(2021年)

2021-09-11 中华医学会眼科学分会 中华眼科杂志. 2021,57(09)

我国角膜屈光手术的数量逐年递增,手术质量也在不断提升,呈现出多元化、规范化的趋势。干眼仍然是各种角膜屈光手术前后较为常见及需要解决的问题之一。在角膜屈光手术的围手术期对干眼进行规范化诊断和治疗,对于提

中文标题:

中国角膜屈光手术围手术期干眼诊疗专家共识(2021年)

发布日期:

2021-09-11

简要介绍:

我国角膜屈光手术的数量逐年递增,手术质量也在不断提升,呈现出多元化、规范化的趋势。干眼仍然是各种角膜屈光手术前后较为常见及需要解决的问题之一。在角膜屈光手术的围手术期对干眼进行规范化诊断和治疗,对于提高患者术后视觉质量和满意度具有重要意义,也是眼科医疗质量控制和规范化管理的重要内容。为此中华医学会眼科学分会眼视光学组与中国医师协会眼科医师分会眼视光学组、屈光手术学组携手,针对角膜屈光手术前后干眼的发病机制、术前评估和处理、术后护理和治疗等,结合国内外研究结果和我国临床实际情况,经过充分、认真讨论形成专家共识意见,以供眼科医师在临床工作中参考。(中华眼科杂志,2021,57:644-650)
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国角膜屈光手术围手术期干眼诊疗专家共识(2021年).pdf)] GetToolGuiderByIdResponse(projectId=1, id=a3c1d1c002192334, title=中国角膜屈光手术围手术期干眼诊疗专家共识(2021年), enTitle=, guiderFrom=中华眼科杂志. 2021,57(09), authorId=0, author=, summary=我国角膜屈光手术的数量逐年递增,手术质量也在不断提升,呈现出多元化、规范化的趋势。干眼仍然是各种角膜屈光手术前后较为常见及需要解决的问题之一。在角膜屈光手术的围手术期对干眼进行规范化诊断和治疗,对于提, cover=https://img.medsci.cn/2021923/1632411348841_2020535.jpg, journalId=0, articlesId=null, associationId=186, associationName=中华医学会眼科学分会, associationIntro=中华医学会眼科学分会会员1950年有101人,2000年登记会员为4000人。当时全国眼科医师为22,000人左右。中华眼科学会逐年扩大了与国际眼科学界的联系,主持召开过多次国际眼科学术会议。经赵家良教授的努力,中华眼科学会终于2004年、2005年成为了国际眼科学会联盟(IFOS)和亚太眼科学会(APAO)的成员。 如今,中华医学会眼科学分会已传承至第10届领导集体,赵堪兴教授为主任委员。 1950年10月1日,中华眼科学会自己的刊物《中华眼科杂志》创刊号正式出版。, copyright=0, guiderPublishedTime=Sat Sep 11 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">我国角膜屈光手术的数量逐年递增,手术质量也在不断提升,呈现出多元化、规范化的趋势。干眼仍然是各种角膜屈光手术前后较为常见及需要解决的问题之一。在角膜屈光手术的围手术期对干眼进行规范化诊断和治疗,对于提高患者术后视觉质量和满意度具有重要意义,也是眼科医疗质量控制和规范化管理的重要内容。为此中华医学会眼科学分会眼视光学组与中国医师协会眼科医师分会眼视光学组、屈光手术学组携手,针对角膜屈光手术前后干眼的发病机制、术前评估和处理、术后护理和治疗等,结合国内外研究结果和我国临床实际情况,经过充分、认真讨论形成专家共识意见,以供眼科医师在临床工作中参考。(中华眼科杂志,2021,57:644-650)</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=10207, tagName=干眼)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21064, categoryName=梅斯医学-干眼症网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10207, guiderKeyword=干眼, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7318, appHits=216, showAppHits=0, pcHits=1105, showPcHits=7102, likes=3, shares=20, comments=8, approvalStatus=1, publishedTime=Thu Sep 23 23:40:40 CST 2021, publishedTimeString=2021-09-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 23 23:36:00 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:37:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国角膜屈光手术围手术期干眼诊疗专家共识(2021年).pdf)])
中国角膜屈光手术围手术期干眼诊疗专家共识(2021年).pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191974, encodeId=c69811919e4da, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb323028901, createdName=1051124944, createdTime=Thu Feb 10 19:24:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191335, encodeId=4ae81191335f5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15021487627, createdName=imp_wym, createdTime=Wed Feb 09 08:58:32 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187957, encodeId=3339118e957b0, content=学习贯彻落实共识,更好的服务于患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:15:13 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073623, encodeId=9e0c10e36232f, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=881c4684367, createdName=397651337, createdTime=Wed Nov 24 20:30:34 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063999, encodeId=83891063999dd, content=很实用,准备好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98015645570, createdName=老兔, createdTime=Tue Oct 26 09:57:24 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2022-02-10 1051124944

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191974, encodeId=c69811919e4da, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb323028901, createdName=1051124944, createdTime=Thu Feb 10 19:24:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191335, encodeId=4ae81191335f5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15021487627, createdName=imp_wym, createdTime=Wed Feb 09 08:58:32 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187957, encodeId=3339118e957b0, content=学习贯彻落实共识,更好的服务于患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:15:13 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073623, encodeId=9e0c10e36232f, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=881c4684367, createdName=397651337, createdTime=Wed Nov 24 20:30:34 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063999, encodeId=83891063999dd, content=很实用,准备好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98015645570, createdName=老兔, createdTime=Tue Oct 26 09:57:24 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2022-02-09 imp_wym

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191974, encodeId=c69811919e4da, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb323028901, createdName=1051124944, createdTime=Thu Feb 10 19:24:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191335, encodeId=4ae81191335f5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15021487627, createdName=imp_wym, createdTime=Wed Feb 09 08:58:32 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187957, encodeId=3339118e957b0, content=学习贯彻落实共识,更好的服务于患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:15:13 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073623, encodeId=9e0c10e36232f, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=881c4684367, createdName=397651337, createdTime=Wed Nov 24 20:30:34 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063999, encodeId=83891063999dd, content=很实用,准备好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98015645570, createdName=老兔, createdTime=Tue Oct 26 09:57:24 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2022-01-25 ms9000001995137444

    学习贯彻落实共识,更好的服务于患者

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191974, encodeId=c69811919e4da, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb323028901, createdName=1051124944, createdTime=Thu Feb 10 19:24:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191335, encodeId=4ae81191335f5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15021487627, createdName=imp_wym, createdTime=Wed Feb 09 08:58:32 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187957, encodeId=3339118e957b0, content=学习贯彻落实共识,更好的服务于患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:15:13 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073623, encodeId=9e0c10e36232f, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=881c4684367, createdName=397651337, createdTime=Wed Nov 24 20:30:34 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063999, encodeId=83891063999dd, content=很实用,准备好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98015645570, createdName=老兔, createdTime=Tue Oct 26 09:57:24 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-11-24 397651337

    太好了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191974, encodeId=c69811919e4da, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb323028901, createdName=1051124944, createdTime=Thu Feb 10 19:24:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191335, encodeId=4ae81191335f5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15021487627, createdName=imp_wym, createdTime=Wed Feb 09 08:58:32 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187957, encodeId=3339118e957b0, content=学习贯彻落实共识,更好的服务于患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:15:13 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073623, encodeId=9e0c10e36232f, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=881c4684367, createdName=397651337, createdTime=Wed Nov 24 20:30:34 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063999, encodeId=83891063999dd, content=很实用,准备好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98015645570, createdName=老兔, createdTime=Tue Oct 26 09:57:24 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-10-26 老兔

    很实用,准备好好学习的

    0